Menu

Category: Pharma Industry

RFK Jr. Touts HHS Budget Plan, PBM Reform & Drug Pricing Efforts; Rep. Harshbarger Suggests 340B Contract Changes

Shannon Young, Associate Editor/Senior Writer Views
HHS Secretary Robert F. Kennedy Jr. testified before the U.S. House E&C Committee’s Health Subcommittee Tuesday on the president’s HHS budget.
Health and Human Services (HHS) Secretary Robert F. Kennedy Jr. this week defended President Donald Trump’s Fiscal Year 2026 proposed [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
…
Read More »

Four Drugmakers Announce New State Exemptions from 340B Contract Pharmacy Restrictions

William Newton, Associate Editor/Senior Writer Views
Amgen is one of four drugmakers to have recently exempted new states from its 340B contract pharmacy restrictions.
Drugmakers Amgen, GSK, Merck and Sobi recently announced they are exempting more states from their 340B contract pharmacy restrictions amid [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
…
Read More »

News Alert

Maine Enacts 340B Contract Pharmacy Access Law with Added Hospital Reporting Requirements

William Newton, Associate Editor/Senior Writer Views
Maine Gov. Janet Mills (D) on June 20 signed a budget bill with 340B contract pharmacy protections and expanded hospital reporting requirements.
Maine recently became the 20th state to enact a 340B contract pharmacy access law as part of a sweeping budget [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
…
Read More »

Drugmakers, Hospital Group Appeal Dueling Aspects of 340B Rebate Ruling

William Newton, Associate Editor/Senior Writer Views
Multiple drugmakers and an intervening hospital trade group are appealing different aspects of a federal district judge's ruling on 340B rebates.
Three drugmakers and a drug industry tech firm are urging a federal appeals court to overturn a ruling that blocked [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
…
Read More »

Q+A: Kalderos CEO Angie Franks Talks Truzo, 340B Program Transparency

Shannon Young and William Newton, Associate Editor/Senior Writer Views
Kalderos CEO Angie Franks recently spoke with 340B Report about the current battle over 340B rebate models, among other things.
Health technology company Kalderos has made waves in the 340B world in recent years after emerging as a key player [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
…
Read More »

Trump’s ‘Most Favored Nation’ Order Could Lower 340B Ceiling Prices, but Key Details Remain Unclear

William Newton, Associate Editor/Senior Writer Views
President Donald Trump's "most favored nation" executive order has unclear effects on the 340B program.
President Donald Trump’s recent executive order directing federal agencies to pursue “most favored nation” (MFN) pricing for prescription drugs could [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
…
Read More »

NACHC Raises Concerns About 340B Rebates, Various Stakeholders Meet with Trump Administration on Rebate Guidance

Shannon Young, Associate Editor/Senior Writer Views
NACHC raised concerns about implementing a 340B rebate model in a June 17 letter sent to CMS Administrator Mehmet Oz and HRSA Administrator Thomas Engels.
A national 340B community health center organization, which has faced criticism for its partnership with a powerful drug industry trade [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
…
Read More »

AHA Report: 340B Hospitals Face More Federal Oversight, Fare Better in Audits; HRSA Releases Latest Drugmaker Audit

Shannon Young, Associate Editor/Senior Writer Views
A new AHA analysis found that 340B hospitals face more federal oversight and routinely see higher rates of compliance in federal audits than drugmakers.
Hospitals that participate in the 340B program face more federal oversight and routinely see higher rates of compliance in federal [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
…
Read More »

D.C. Federal District Court Dismisses Hospital Lawsuits Over J&J’s Controversial 340B Audit Requests

Shannon Young, Associate Editor/Senior Writer Views
A Washington D.C. federal judge this week dismissed lawsuits Oregon Health & Science University and four other hospitals filed against HRSA for authorizing J&J to audit their 340B program records.
A Washington D.C. federal court this week threw out five hospital lawsuits challenging the Health Resources and Services Administration (HRSA) [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
…
Read More »

Maine Passes 340B Contract Pharmacy Access Bill with Added Hospital Reporting Requirements, Sends to Governor

William Newton, Associate Editor/Senior Writer Views
The Maine Legislature passed a 340B contract pharmacy access bill with added hospital reporting requirements on June 16.
Maine lawmakers yesterday passed a 340B contract pharmacy access bill that adds new hospital reporting requirements on top of an [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
…
Read More »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×

*Sign up for news summaries and alerts from 340B Report

Site Footer Live